市场调查报告书
商品编码
1402736
亚太地区母乳强化剂市场预测至 2030 年 - 区域分析 - 按形式(粉末和液体)和配销通路(线上和线下)Asia Pacific Human Milk Fortifier Market Forecast to 2030 - Regional Analysis - by Form (Powder and Liquid) and Distribution Channel (Online and Offline) |
亚太母乳强化剂市场预计将从2023年的7,953万美元成长到2030年的1.5,905亿美元;预计2023年至2030年CAGR为10.4%。
发展中国家意识的提高推动亚太母乳强化剂市场
近年来,婴儿营养品已成为亚太地区最赚钱的市场之一。人口成长、经济稳定发展和人均收入增加是推动市场的主要因素。中国、印度和韩国等国家的人们高度关注儿童的健康和福祉,并广泛采用母乳强化剂来支持他们的生长和发育。母乳强化剂的概念对于新兴经济体的许多人来说是新的,人们意识的不断增强预计将为市场成长创造有利可图的机会。由于人们对母乳强化剂的益处(例如促进生长和骨骼发育)的认识不断提高,母乳强化剂市场正在获得巨大的吸引力。发展中国家的健康协会正在采取措施促进早产儿的整体生长并改善营养。例如,2021 年 7 月,NeoLacta Lifesciences 宣布根据世界卫生组织 (WHO) 的指导方针在印度开发 100% 母乳强化剂。该产品旨在提高新生儿的营养护理品质。
因此,发展中国家对母乳强化剂的认识不断提高,预计将在预测期内为市场提供利润丰厚的成长机会。
亚太地区母乳强化剂市场概况
家长和医疗保健专业人员对母乳强化剂营养益处的认识不断提高,推动了对该产品的需求。此外,新生儿护理的进步提高了早产儿的存活率,导致对母乳强化剂的需求增加。这些强化剂为早产儿提供必需的营养素并促进更好的健康结果。随着亚太地区可支配所得水准的上升,越来越多的父母能够负担得起优质保健产品,包括母乳强化剂。这促进了市场的成长,因为父母愿意投资能够改善孩子健康和福祉的产品。此外,亚太地区医疗基础设施的扩张,包括新生儿加护病房(NICU),为母乳强化剂市场的成长创造了有利的环境。医院和医疗机构拥有更好的装备,可以为早产儿提供专门护理,从而促进母乳强化剂需求的增加。
亚太地区母乳强化剂市场收入及 2030 年预测(百万美元)
亚太地区母乳强化剂市场区隔
亚太地区母乳强化剂市场依据形式、配销通路和国家进行细分。根据形式,亚太母乳强化剂市场分为粉末和液体。到 2023 年,粉末细分市场将占据更大的市场份额。
根据配销通路,亚太母乳强化剂市场分为线上和线下。 2023年,线下细分市场占有更大的市场占有率。
依国家/地区划分,亚太地区母乳强化剂市场分为澳洲、中国、印度、日本、韩国和亚太地区其他地区。 2023年,中国在亚太母乳强化剂市场占据主导地位。
Abbott Laboratories、NeoLacta Lifesciences Pvt Ltd、Nestle SA、Prolacta Bioscience Inc、Lead Care International Ltd、Raptakos、Brett & Co Ltd、Danone SA 和 Reckitt Benckiser Group Plc 是亚太母乳强化剂市场上的一些领先公司。
The Asia Pacific human milk fortifier market is expected to grow from US$ 79.53 million in 2023 to US$ 159.05 million by 2030; it is estimated to grow at a CAGR of 10.4% from 2023 to 2030.
Rising Awareness in Developing Countries fueling the Asia Pacific Human Milk Fortifier Market
In recent years, infant nutrition has been one of the most lucrative markets in Asia Pacific. Rise in population, steady economic development, and increase in per capita income are among the major factors driving the market. People in countries such as China, India, and South Korea are highly concerned about their children's health and well-being and are widely adopting human milk fortifiers to support their growth and development. The concept of human milk fortifiers is new to many people in emerging economies, and the increasing awareness among people is expected to create lucrative opportunities for the market growth. The human milk fortifier market is gaining significant traction owing to increasing awareness regarding the benefits of human milk fortifiers, such as promoting growth and bone development. Health associations in the developing countries are taking initiatives to boost overall growth and improve nutrition in preterm babies. For instance, in July 2021, NeoLacta Lifesciences announced the development of a 100% human milk fortifier in India as per the guidelines of the World Health Organization (WHO). The product aims to improve the quality of nutritional care for newborns.
Thus, the rising awareness about human milk fortifiers in developing countries is expected to provide lucrative growth opportunities for the market during the forecast period.
Asia Pacific Human Milk Fortifier Market Overview
Increased awareness among parents and healthcare professionals about the nutritional benefits of human milk fortifiers is driving the demand for this product. Also, advances in neonatal care have improved the survival rates of premature infants, leading to a higher demand for human milk fortifiers. These fortifiers provide essential nutrients and promote better health outcomes for preterm babies. As disposable income levels rise in Asia Pacific, more parents can afford premium healthcare products, including human milk fortifiers. This has contributed to the market growth, as parents are willing to invest in products that can improve their child's health and well-being. Moreover, the expansion of healthcare infrastructure, including neonatal intensive care units (NICUs), across Asia Pacific has created a favorable environment for the human milk fortifier market growth. Hospitals and healthcare facilities are better equipped to provide specialized care for premature infants, contributing to the increased demand for human milk fortifiers.
Asia Pacific Human Milk Fortifier Market Revenue and Forecast to 2030 (US$ Million)
Asia Pacific Human Milk Fortifier Market Segmentation
The Asia Pacific human milk fortifier market is segmented based on form, distribution channel, and country. Based on form, the Asia Pacific human milk fortifier market is bifurcated into powder and liquid. The powder segment held a larger market share in 2023.
Based on distribution channel, the Asia Pacific human milk fortifier market is bifurcated into online and offline. The offline segment held a larger market share in 2023.
Based on country, the Asia Pacific human milk fortifier market is segmented into Australia, China, India, Japan, South Korea, and the Rest of Asia Pacific. China dominated the Asia Pacific human milk fortifier market in 2023.
Abbott Laboratories, NeoLacta Lifesciences Pvt Ltd, Nestle SA, Prolacta Bioscience Inc, Lead Care International Ltd, Raptakos, Brett & Co Ltd, Danone SA, and Reckitt Benckiser Group Plc are some of the leading companies operating in the Asia Pacific human milk fortifier market.